miR-60047 and miR-33a42 directly inhibit METTL3 targeting EGFR, subsequently, lowering the levels of the phosphorylated form of AKT and NSCLC cell proliferation. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.